Your search returned 3 results.

Results
	1.	Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. [electronic resource] by Kalsekar, Iftekhar Wagner, Jan-Samuel DiBonaventura, Marco Bates, Jay Forbes, Robert Hebden, Tony Producer: 20121018 In: Health and quality of life outcomes vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. [electronic resource] by Abouzaid, Safiya Jutkowitz, Eric Foley, Kathy A Pizzi, Laura T Kim, Edward Bates, Jay Producer: 20110307 In: Population health management vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Cognitive development in schizophrenia: follow-back from the first episode. [electronic resource] by Bilder, Robert M Reiter, Gail Bates, Jay Lencz, Todd Szeszko, Philip Goldman, Robert S Robinson, Delbert Lieberman, Jeffrey A Kane, John M Producer: 20060414 In: Journal of clinical and experimental neuropsychology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search